Investor profile
Invivo Capital Partners has backed 7 European tech companies across 10 funding rounds between 2018 and 2026, joining rounds totalling €127M. Most active in Healthtech and Agritech. Data as of 7 Aug 2026.
Also recorded as: InVivo · Invivo Partners
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Arthex Biotech | Spain | 3 | €78M |
| Telum Therapeutics | Spain | 2 | €22M |
| Integra Therapeutics | Spain | 1 | €11M |
| Onechain Immunotherapeutics | Spain | 1 | €6.7M |
| Agdatahub | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Arthex Biotech | Series B | €42M | 2023-05 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| Telum Therapeutics | Series A | €18M | 2026-07 |
| Integra Therapeutics |
| 1 |
| €4.8M |
| MiiMOSA | France | 1 | €3.0M |
| Arthrex Biotech | Spain | 1 | €1.5M |
| Seed |
| €11M |
| 2025-09 |
| Onechain Immunotherapeutics | Seed | €6.7M | 2023-06 |
| Agdatahub | Other | €4.8M | 2023-03 |
| Arthex Biotech | Seed | €4.3M | 2020-07 |
| Telum Therapeutics | Seed | €4.1M | 2020-07 |
| MiiMOSA | Other | €3.0M | 2018-02 |
| Arthrex Biotech | Other | €1.5M | 2020-09 |
